newcleo Begins Trading on Nasdaq Under Symbol "NWCL"

newcleo plc, a nuclear technology company, began trading on the Nasdaq Global Select Market on September 22, 2026, under the ticker symbols NWCL and NWCLW. The company plans to use the capital to accelerate its reactor and fuel manufacturing technology deployment in Europe and the U.S. newcleo aims to deliver clean, safe, and sustainable energy at competitive costs.

Original reporting
Published Sep 23, 2026, 5:59 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 8:36 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
newcleo Begins Trading on Nasdaq Under Symbol "NWCL" — source image
Decision brief

The 30-second read

$NWCLNeutralHigh
01

Why it matters

The Nasdaq debut provides capital and visibility, but the company's long‑term value depends on licensing, construction milestones, and market adoption.

02

Market read

The listing introduces a new clean‑energy play to public markets, offering a speculative opportunity for investors focused on nuclear innovation.

03

What to watch

Regulatory approvals and commercial contracts are still early‑stage, posing execution risk.

Relevance 6/10Novelty 8/10Timing: today pre‑market

Background

newcleo is a developer of lead‑cooled fast reactors and recycled‑fuel technology, aiming to commercialize modular nuclear power.

Company-level read

Ticker impact

$NWCLNeutralHigh confidence
Context

newcleo plc's ordinary shares and warrants began trading on Nasdaq today, providing the first market access to the company.

Expected impact

Potential short-term volatility as investors assess the debut price.

Evidence & confidence

First day of trading typically sees price swings; no prior market price existed.

Market effects

Adds a listed pure‑play nuclear modular reactor company to the clean‑energy sector.

May attract European and US investors interested in advanced nuclear tech.

Limited to niche energy investors but could signal broader interest in nuclear innovation.

Counterpoint

The market may overprice the debut, leading to a pull‑back after initial hype.

Key entities

  • Stefano Buono

    CEO and co‑founder of newcleo, quoted in the release.

Related articles

$NWCLMed

A scale maker joins newcleo. Its equipment will help track nuclear materials at planned fuel plants.

newcleo plc (Nasdaq: NWCL) acquired Bonifait Pesage, a French nuclear-grade scale maker, to support its US and European MOX fuel manufacturing. The deal aligns with newcleo's vertical integration strategy, securing supply and reducing exposure. Bonifait Pesage's revenue is approximately $50M. The acquisition aims to enhance tracking and control of nuclear materials.

$AMZNMedAI 8/10

Anthropic Weighs Bigger IPO as Investor Demand Nears $500 Billion

Anthropic, the company behind AI models, is considering expanding its IPO and pricing shares above $80 after $500B in investor interest. Initial plans were 825M shares at $70-$78, raising up to $64.35B. Investors include Google, Microsoft, Nvidia, and AMD. Revenue grew 1,200% YoY to $33.24B, but net loss widened to $104B. Final pricing and shares sold are pending.

$ANTHighAI 9/10

One of AI's most notorious 'doomers' stands to make billions in Anthropic's IPO

Jaan Tallinn, a tech billionaire and AI 'doomer,' is poised to gain significantly from Anthropic's upcoming IPO. Tallinn, who co-founded Skype, led Anthropic's first funding round in 2018. The company, valued at around $1.4 trillion, is set to list on the Nasdaq under the ticker ANT. Tallinn's exact holdings are undisclosed, but his initial investment could yield tens of billions.

$ANTHighAI 8/10

Anthropic IPO draws massive demand ahead of debut

Anthropic, maker of the Claude AI platform, is set to debut on the Nasdaq under ticker ANT. Its IPO, initially priced at $70-$78 per share for a $1.4T valuation, has attracted nearly $500B in interest, potentially pricing above $80. The company reported Q3 revenue of $17B, up 1,127% YoY, but remains unprofitable. Investors will scrutinize its $900B infrastructure commitments and revenue growth sustainability.

$ANTMed

Anthropic (ANT) Pricing Largest IPO in History: What To Expect

Anthropic (ANT) is finalizing its IPO, expected to be the largest in history, with shares priced between US$70 and US$78. The company aims to raise ~US$90.4 billion, with a market cap of ~US$1.4 trillion at the open. Key investors include Google and Nvidia. Revenue grew to an annualized US$81 billion by October 31, but the company remains loss-making.